IGF action in vivo is acutely regulated by IGF-binding protein-1 (IGFBP-1) and its phosphorylation state is implicated in modulating these effects. Since IGFs have an important regulatory role in adipocyte function, we investigated the effects of phosphorylated IGFBP-1 (pIGFBP-1) and non-phosphorylated IGFBP-1 (npIGF BP-1) on 3T3-L1 preadipocyte proliferation and adipocyte metabolism. IGFs stimulated clonal expansion of 3T3-L1 cells (IGF-I more potently than IGF-II (EC(50): 30 nM and 50 nM)). npIGFBP-1 inhibited IGF-I (50 nM) clonal expansion at a 5:1 molar ratio (P<0.01), whereas pIGFBP-1 (purified from HepG2 cell medium) abolished clonal expansion at a 1:1 molar ratio (P<0.005). In contrast, IGF-II-induced clonal expansion was inhibited 100% at a 1:1 molar ratio of npIGFBP-1. In mature adipocytes, IGF-I was equipotent with insulin in stimulating glucose uptake (EC(50): 10 nM) and inhibiting isoproterenol-induced lipolysis (EC(50): 15 nM). npIGFBP-1 completely reversed IGF-I effects at a 1:1 molar ratio (P<0.01). In summary, IGFs rather than insulin are potent regulators of clonal expansion in 3T3-L1 preadipocytes. Importantly, IGFs are equipotent with insulin in regulating adipocyte metabolism. IGFBP-1 inhibits IGF effects on preadipocyte proliferation and adipocyte metabolism, with pIGFBP-1 being more potent than npIGFBP-1 at inhibiting mitogenic actions. Since IGFBP-1 is acutely regulated by insulin, this could have important consequences in hyperinsulinaemic and insulin-resistant states.

This article has been cited by other articles:

				S. B. Wheatcroft, M. T. Kearney, A. M. Shah, V. A. Ezzat, J. R. Miell, M. Modo, S. C.R. Williams, W. P. Cawthorn, G. Medina-Gomez, A. Vidal-Puig, et al. IGF-Binding Protein-2 Protects Against the Development of Obesity and Insulin Resistance Diabetes, February 1, 2007; 56(2): 285 - 294. [Abstract] [Full Text] [PDF]

				B. Wagoner, D. B. Hausman, and R. B. S. Harris Direct and indirect effects of leptin on preadipocyte proliferation and differentiation Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1557 - R1564. [Abstract] [Full Text] [PDF]

				S. S. Y. Chan, S. M. Twigg, S. M. Firth, and R. C. Baxter Insulin-Like Growth Factor Binding Protein-3 Leads to Insulin Resistance in Adipocytes J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6588 - 6595. [Abstract] [Full Text] [PDF]

				K. W. Siddals, E. Marshman, M. Westwood, and J. M. Gibson Abrogation of Insulin-like Growth Factor-I (IGF-I) and Insulin Action by Mevalonic Acid Depletion: SYNERGY BETWEEN PROTEIN PRENYLATION AND RECEPTOR GLYCOSYLATION PATHWAYS J. Biol. Chem., September 10, 2004; 279(37): 38353 - 38359. [Abstract] [Full Text] [PDF]